| 2020-01 | Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials | 유대현 |
| 2020-01 | Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity | 유대현 |
| 2016-09 | Strain sonoelastography of inflammatory myopathies: comparison with clinical examination, magnetic resonance imaging and pathologic findings | 유대현 |
| 2017-09 | Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry | 유대현 |
| 2018-07 | Switching to biosimilars in the treatment of rheumatic diseases | 유대현 |
| 2013-08 | Tacrolimus treatment increases bone formation in patients with rheumatoid arthritis | 유대현 |
| 2020-10 | Temporal relationship between idiopathic inflammatory myopathies and malignancies and its mortality: a nationwide population-based study | 유대현 |
| 2012-08 | Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis | 유대현 |
| 2018-12 | Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea | 유대현 |
| 2013-12 | Treating rheumatoid arthritis to target: recommendations assessment questionnaire in Korea | 유대현 |
| 2017-08 | Treatment of adult-onset still's disease: up to date | 유대현 |
| 2013-07 | Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: An Asian perspective | 유대현 |
| 2011-03 | Upregulation of interleukin-1 beta production by 1,25-Dihydroxyvitamin D(3) in activated human macrophages | 유대현 |
| 2013-08 | The Urate-lowering Efficacy and Safety of Febuxostat in Korean Patients with Gout | 유대현 |
| 2017-11 | Utility and drawbacks of [18] F-fluorodeoxyglucose positron emission tomography in the evaluation of adult-onset Still's disease | 유대현 |
| 2013-10 | The Utility of Magnetic Resonance Imaging in Inflammatory Myopathy | 유대현 |
| 2017-01 | What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis? | 유대현 |
| 2014-04 | 류마티스관절염에서 DAS28에 근거한 보험급여기준 적용시 항 TNF제제 대상 환자 예측 | 유대현 |
| 2011-09 | 한국인 류마티스관절염 환자에서 항 TNF 제제의 지속성에 관한 연구 | 유대현 |
| 2015-08 | 항 Tumor Necrosis Factor 제제 사용 전 잠복결핵 진단 전략에 따른 결핵 발생율 | 유대현 |
